Innovatus Life Sciences Acquisition Corp. (ILAC)
Innovatus Life Sciences Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
| Market Cap | 224.60M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 22.46M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
News
Innovatus Life Sciences Acquisition Corp. has filed to go public with an IPO on the NASDAQ.
About ILAC
Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to initially focus our search on identifying a prospective target business in the life sciences sector. Our sponsor is an affiliate of Innovatus Capital Partners, LLC, a boutique private equity firm with 27 professionals focused on creating value in special situations, growth equity, emergin... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Pending |
| CEO David Schiff | Country United States |
| Stock Exchange NASDAQ | Ticker Symbol ILAC |